Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 229-029-9 | CAS number: 6406-56-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Description of key information
Acute Oral Toxicity:
In Acute oral toxicity ,LD50 value for target substance C.I. Acid Red 151(CAS NO: 6406-56-0) was considered to be 7736 mg/kg bw,and for differentstudies available on the structurally similar read across substance Disodium 6-hydroxy-5-[(4-sulphonatophenyl)azo]naphthalene-2-sulphonate(2783-94-0) was considered to be >6000 mg/kg bw ;for FD & C Red NO. 40 (25956-17-6) was considered to be >10000 mg/kg bw and for Disodium 5-amino-4-hydroxy-3-(phenylazo) naphthalene-2, 7-disulphonate (CAS No. 3567-66-6) was considered to be 5000 mg/kg bw. All these studies concluded that the LD50 value is greater than 2000 mg/kg bw. Thus, comparing this value with the criteria of CLP regulation, C.I. Acid Red 151(CAS NO: 6406-56-0) cannot be classified for acute oral toxicity.
Acute Inhalation Toxicity:
Sodium 4-(4-(2-hydroxynaphthalenylazo)phenylazo)benzenesulphonate (6406-56-0) has very low vapor pressure (5.19E-021 Pa.), so the potential for the generation of inhalable vapours is very low. Also the normal conditions of use of this substance will not result in aerosols, particles or droplets of an inhalable size, so exposure to humans via the inhalatory route will be highly unlikely and therefore the acute inhalation toxicity end point was considered for waiver.
Acute Dermal Toxicity:
In Acute dermal toxicity, LD50 value was predicted based on OECD QSAR toolbox for target substance Sodium 4-(4-(2-hydroxynaphthalenylazo)phenylazo)benzenesulphonate (6406-56-0) was estimated to be 6184.56 mg/kg bw,and for differentstudies available on structurally similar read across substance Disodium 5-amino-4-hydroxy-3-(phenylazo) naphthalene-2, 7-disulphonate (CAS No. 3567-66-6) was considered to be >2000 mg/kg bw and for Tetra sodium 1-acetamido-2-hydroxy-3-(4-((4-sulphonatophenylazo)-7-sulphonato-1-naphthylazo))naphthalene-4,6-disulphonate (CAS No. 2519-30-4) was considered to be >2000 mg/kg bw. All these studies concluded that the LD50 value is greater than 2000 mg/kg bw. Thus, comparing this value with the criteria of CLP regulation, Sodium 4-(4-(2-hydroxynaphthalenylazo)phenylazo)benzenesulphonate (6406-56-0) cannot be classified for acute dermal toxicity.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- data from handbook or collection of data
- Justification for type of information:
- data is from authoritative database
- Qualifier:
- according to guideline
- Guideline:
- other: as mentioned below
- Principles of method if other than guideline:
- The acute oral L50 test of C.I. Acid Red 151(CAS NO: 6406-56-0) in ChR-CD male rat.
- GLP compliance:
- not specified
- Test type:
- other: no data available
- Limit test:
- no
- Specific details on test material used for the study:
- - Name of test material (as cited in study report):C.I. Acid Red 151
- Molecular formula :C22H15N4O4S.Na
- Molecular weight :455.448 g/mol
- Substance type:Organic
- Physical state:Solid
-Purity70% (22% Active Ingredient;35% 2-Ethoxyethanol;2% ''Merpol" DA;1% Compound 85;5% "Pluronic" L 42;5% NaOH)
- Impurities (identity and concentrations):30% - Species:
- rat
- Strain:
- other: ChR-CD
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- Details on test animal:
TEST ANIMALS
- Age at study initiation:young and adult rats were used - Route of administration:
- other: Oral (intragastric intubation)
- Vehicle:
- water
- Details on oral exposure:
- No data available
- Doses:
- 7500, 8000, 8500 and 9500 mg/kg bw
- No. of animals per sex per dose:
- Total:40 animals
7500 mg/kg bw: 10 male
8000 mg/kg bw: 10 male
8500 mg/kg bw: 10 male
9500 mg/kg bw: 10 male - Control animals:
- not specified
- Details on study design:
- Details on study design:
- Duration of observation period following administration: 14 days
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs - Statistics:
- The LD50 value was calculated from the mortality data using the method of D. J. Finney.
- Preliminary study:
- no data available
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- 7 736 mg/kg bw
- 95% CL:
- 7 347 - 7 977
- Remarks on result:
- other: 50% mortality was observed
- Mortality:
- At 7500 mg/kg bw – 2/10 rats died
At 8000mg/kg bw – 9/10 rats died.
At 8500 mg/kg bw – 9/10 rats died.
At 9500 mg/kg bw – 10/10 rats died. - Clinical signs:
- other: Belly-to-cage posture, eyes half closed, prostration, pallor, stained mouth and compound and/or metabolite(s) in feces after dosing at 9,500 mg/kg. Belly-to-cage posture, eyes half closed, lethargy, prostration, labored breathing, stained nose and mouth,
- Gross pathology:
- No data available
- Other findings:
- No data available
- Interpretation of results:
- other: not classified
- Conclusions:
- The acute oral LD50 value of C.I. Acid Red 151 is considered to be 7,736 mg/kg (95% Confidence Limits:7347 mg/kg bw -7977 mg/kg bw) in ChR-CD male rats when test material was administered by intragastric intubation following 14 days of observation period.
- Executive summary:
Acute oral toxicity (LD50) test ofC.I. Acid Red 151was conducted in ChR-CD male rat.Test substancewas administered 7500, 8000, 8500 and 9500 mg/kg by intragastric intubation to four groups of ten rat. After 14 days observation.Mortality observed were 2/10 at dose 7500 mg/kg; 9/10 at 8000 and 8500 mg/kg and all animals died at dose 9500 mg/kg bw. clinical signs were observed at different doses which are as follows:Belly-to-cage posture, eyes half closed, prostration, pallor, stained mouth and compound and/or metabolite(s) in feces after dosing at 9,500 mg/kg.Belly-to-cage posture, eyes half closed, lethargy, prostration, labored breathing, stained nose and mouth, stained and wet perineal &rea and weight loss after dosing at 8,500 mg/kg.Belly-to-cage posture, eyes half closed, lethargy, prostration, chromodacryorrhea, irregular breathing, labored creathing, stained nose and mouth, stained and wet perineal area and weight loss after dosing at 8,000 mg/kg. Therefore,the acute oral L50 value ofC.I. Acid Red 151(95% Confidence Limits:7347 mg/kg bw -7977 mg/kg bw) is considered to be7,736 mg/kg in male ChR-CD rat.
Reference
Dose(mg/kg) |
Average Body Weight (g) |
Mortality ratio |
7500 |
267 |
2/10 |
8000 |
256 |
9/10 |
8500 |
266 |
9/10 |
9500 |
244 |
10/10 |
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 7 736 mg/kg bw
- Quality of whole database:
- Data is Klimisch 2
Acute toxicity: via inhalation route
Link to relevant study records
- Endpoint:
- acute toxicity: inhalation
- Data waiving:
- other justification
- Justification for data waiving:
- other:
Reference
Endpoint conclusion
- Quality of whole database:
- Waiver
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Type of information:
- (Q)SAR
- Adequacy of study:
- weight of evidence
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- results derived from a valid (Q)SAR model and falling into its applicability domain, with limited documentation / justification
- Justification for type of information:
- Data is predicted using OECD QSAR toolbox version 3.4 and QMRF report has been attached
- Qualifier:
- according to guideline
- Guideline:
- other: as mentioned below
- Principles of method if other than guideline:
- Prediction was done by using OECD QSAR toolbox v3.4,2017
- GLP compliance:
- not specified
- Test type:
- other: estimated data
- Limit test:
- no
- Specific details on test material used for the study:
- - Name of test material (IUPAC name): Sodium 4-(4-(2-hydroxynaphthalenylazo)phenylazo)benzenesulphonate
- Common name: Acid Red 151
- Molecular formula: C22H15N4O4S.Na
- Molecular weight: 455.448 g/mol
- Smiles notation: c12c(\N=N\c3ccc(\N=N\c4ccc(S(O)(=O)=O)cc4)cc3)c(ccc1cccc2)O.[Na+]
- InChl: 1S/C22H16N4O4S.Na/c27-21-14-5-15-3-1-2-4-20(15)22(21)26-25-17-8-6-16(7-9-17)23-24-18-10-12-19(13-11-18)31(28,29)30;/h1-14,27H,(H,28,29,30);/q;+1/b24-23+,26-25+;
- Substance type: Organic - Species:
- rabbit
- Strain:
- other: albino
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- No data available
- Type of coverage:
- semiocclusive
- Vehicle:
- unchanged (no vehicle)
- Details on dermal exposure:
- No data available
- Duration of exposure:
- 24 hours
- Doses:
- 6184.56 mg/kg bw
- No. of animals per sex per dose:
- No data available
- Control animals:
- not specified
- Details on study design:
- No data available
- Statistics:
- No data available
- Preliminary study:
- No data available
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- 6 184.56 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: 50% Mortality was observed
- Mortality:
- No data available
- Clinical signs:
- other: No data available
- Gross pathology:
- No data available
- Other findings:
- No data available
- Interpretation of results:
- other: not classified
- Conclusions:
- The LD50 value was estimated to be 6184.56 mg/kg bw,when male albino rabbits were semiocclusively exposed with Sodium 4-(4-(2-hydroxynaphthalenylazo)phenylazo)benzenesulphonate (6406-56-0) by dermal application for 24 hours.
- Executive summary:
In a prediction done by SSS (2017) using the OECD QSAR toolbox with log kow as the primary descriptor, the acute dermal toxicity was estimated for Sodium 4-(4-(2-hydroxynaphthalenylazo)phenylazo)benzenesulphonate (6406-56-0).The LD50 was estimated to be 6184.56 mg/kg bw,when male albino rabbits were semiocclusively exposed with Sodium 4-(4-(2-hydroxynaphthalenylazo)phenylazo)benzenesulphonate (6406-56-0)by dermal application for 24 hours.
Reference
The
prediction was based on dataset comprised from the following
descriptors: LD50
Estimation method: Takes average value from the 5 nearest neighbours
Domain logical expression:Result: In Domain
((("a"
or "b" or "c" )
and "d" )
and ("e"
and "f" )
)
Domain
logical expression index: "a"
Referential
boundary: The
target chemical should be classified as SN1 AND SN1 >> Nitrenium Ion
formation AND SN1 >> Nitrenium Ion formation >> Aromatic azo by DNA
binding by OECD
Domain
logical expression index: "b"
Referential
boundary: The
target chemical should be classified as Strong binder, OH group by
Estrogen Receptor Binding
Domain
logical expression index: "c"
Referential
boundary: The
target chemical should be classified as Acid moiety AND Phenols AND Salt
by Aquatic toxicity classification by ECOSAR
Domain
logical expression index: "d"
Referential
boundary: The
target chemical should be classified as High (Class III) by Toxic hazard
classification by Cramer (original) ONLY
Domain
logical expression index: "e"
Parametric
boundary:The
target chemical should have a value of log Kow which is >= 0.715
Domain
logical expression index: "f"
Parametric
boundary:The
target chemical should have a value of log Kow which is <= 5.76
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 6 184.56 mg/kg bw
- Quality of whole database:
- Data is Klimisch 2 and from QSAR toolbox 3.4
Additional information
Acute Oral Toxicity:
In different studies, Sodium 4-(4-(2-hydroxynaphthalenylazo)phenylazo)benzenesulphonate (6406-56-0) has been investigated for acute oral toxicity to a greater or lesser extent. Often the studies are based on in vivo experiments and estimated data in rodents, i.e. most commonly in rats for Sodium 4-(4-(2-hydroxynaphthalenylazo)phenylazo)benzenesulphonate (6406-56-0) along with the study available on the structurally similar read across substance Disodium 6-hydroxy-5-[(4-sulphonatophenyl)azo]naphthalene-2-sulphonate(2783-94-0);FD & C Red NO. 40 (25956-17-6) and Disodium 5-amino-4-hydroxy-3-(phenylazo) naphthalene-2, 7-disulphonate (CAS No. 3567-66-6).The predicted data using the OECD QSAR toolbox has also been compared with the experimental studies. The studies are summarized as below –
In experimental study conducted by U.S. National Library of Medicine (Chemidplus Database,U.S. National Library of Medicine,2017); RTECS (RTECS (registry of toxic effect of chemical substance data base ), 2017) and NTRL(NTRL NO: OTS0571003, 09/03/92) for the structurally similar read across substance Disodium 6-hydroxy-5-[(4-sulphonatophenyl)azo]naphthalene-2-sulphonate(2783-94-0). Acute oral toxicity (LD50) test of C.I. Acid Red 151 was conducted in ChR-CD male rat.Test substance was administered 7500, 8000, 8500 and 9500 mg/kg by intragastric intubation to four groups of ten rat. After 14 days observation.Mortality observed were 2/10 at dose 7500 mg/kg; 9/10 at 8000 and 8500 mg/kg and all animals died at dose 9500 mg/kg bw. clinical signs were observed at different doses which are as follows:Belly-to-cage posture, eyes half closed, prostration, pallor, stained mouth and compound and/or metabolite(s) in feces after dosing at 9,500 mg/kg.Belly-to-cage posture, eyes half closed, lethargy, prostration, labored breathing, stained nose and mouth, stained and wet perineal &rea and weight loss after dosing at 8,500 mg/kg.Belly-to-cage posture, eyes half closed, lethargy, prostration, chromodacryorrhea, irregular breathing, labored creathing, stained nose and mouth, stained and wet perineal area and weight loss after dosing at 8,000 mg/kg. Therefore,the acute oral L50 value of C.I. Acid Red 151(95% Confidence Limits:7347 mg/kg bw -7977 mg/kg bw) is considered to be7,736 mg/kg in male ChR-CD rat.
The above experimental study was further supported by I. F. GAUNT et. al. (Fd Cosmet. ToxicoL Vol. 5, pp. 747-754,1967) and U.S. National Library of Medicine (Chemidplus Database,U.S. National Library of Medicine,2017) for the structurally similar read across substance FD & C Red NO. 40 (25956-17-6). In a acute oral toxicity study,rats were treated with FD & C Red NO. 40 in the concentration of 10000 mg/kg bw orally. No mortality was observed in treated rats at 10000 mg/kg bw. Therefore,LD50 was considered to be > 10000 mg/kg bw when rats were treated with FD & C Red NO. 40 orally.
This study is further supported by Sustainability Support Services (Europe) AB (study number: 18819, 2016-10-25) for the structurally similar read across substance Disodium 5-amino-4-hydroxy-3-(phenylazo) naphthalene-2, 7-disulphonate (CAS No. 3567-66-6).The acute oral toxicity profile of Disodium 5-amino-4-hydroxy-3-(phenylazo) naphthalene-2, 7-disulphonate was performed in 12 female Sprague Dawley rats. The test material was dissloved in distilled water and given by oral gavage route.Initially, three female animals were treated at the dose level of 300 mg/kg body weight of the test item (Step - I). Administration of the test item at 300 mg/kg did not result in any signs of toxicity and mortality at 24 hours after the dosing. As no mortality was observed at 24 hours after the dosing, three female animals were added to the study and treated with the same dose of 300 mg/kg of the test item (Step - II). Administration of the test item at 300 mg/kg did not result in any signs of toxicity and mortality after the dosing.No mortality was observed at 300 mg/kg dose group, hence additional three female animals were treated with the higher dose of 2000 mg/kg of the test item (Step - I). Administration of the test item at 2000 mg/kg resulted in diarrhoea (reddish colour stools) in all animals with onset at 2 hours and no mortality after the dosing. As no mortality were observed at 24 hours after the dosing, hence additional three female animals were treated with the higher dose of 2000 mg/kg of the test item (Step - II). Administration of the test item at 2000 mg/kg resulted in diarrhoea (reddish colour stools) in all animals with onset at 2 hours and no mortality after the dosing. All animals from 300 mg/kg and 2000 mg/kg dose groups survived through the study period of 14 days. Staining of the stool is attributed to the reddish colour of the test item. Gross pathological examination did not reveal any abnormalities in animals from 300 mg/kg and 2000 mg/kg dose groups. Hence,The LD50 value was considered to be 5000 mg/kg body weight,when female Sprague Dawley rats were treated with Disodium 5-amino-4-hydroxy-3-(phenylazo) naphthalene-2, 7-disulphonate (CAS No. 3567-66-6) orally according to OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method).
Thus, based on the above studies on Sodium 4-(4-(2-hydroxynaphthalenylazo)phenylazo)benzenesulphonate (6406-56-0) and it’s structurally similar read across substances, it can be concluded that LD50 value is greater than 2000 mg/kg bw. Thus, comparing this value with the criteria of CLP regulation, Sodium 4-(4-(2-hydroxynaphthalenylazo)phenylazo)benzenesulphonate (6406-56-0) cannot be classified for acute oral toxicity.
Acute Inhalation Toxicity:
Sodium 4-(4-(2-hydroxynaphthalenylazo)phenylazo)benzenesulphonate (6406-56-0) has very low vapor pressure (5.19E-021 Pa.), so the potential for the generation of inhalable vapours is very low. Also the normal conditions of use of this substance will not result in aerosols, particles or droplets of an inhalable size, so exposure to humans via the inhalatory route will be highly unlikely and therefore the acute inhalation toxicity end point was considered for waiver.
Acute Dermal Toxicity:
In different studies, Sodium 4-(4-(2-hydroxynaphthalenylazo)phenylazo)benzenesulphonate (6406-56-0) has been investigated for acute dermal toxicity to a greater or lesser extent. Often the studies are based on in vivo experiments and estimated data in rodents, i.e. most commonly in rabbits for Sodium 4-(4-(2-hydroxynaphthalenylazo)phenylazo)benzenesulphonate (6406-56-0) along with the study available on the structurally similar read across substance Disodium 5-amino-4-hydroxy-3-(phenylazo) naphthalene-2, 7-disulphonate (CAS No. 3567-66-6) and Tetra sodium 1-acetamido-2-hydroxy-3-(4-((4-sulphonatophenylazo)-7-sulphonato-1-naphthylazo))naphthalene-4,6-disulphonate (CAS No. 2519-30-4).The predicted data using the OECD QSAR toolbox has also been compared with the experimental studies. The studies are summarized as below –
In a prediction done by SSS (2017) using the OECD QSAR toolbox with log kow as the primary descriptor, the acute dermal toxicity was estimated for Sodium 4-(4-(2-hydroxynaphthalenylazo)phenylazo)benzenesulphonate(6406-56-0).The LD50 was estimated to be 6184.56 mg/kg bw,when male albino rabbits were semiocclusively exposed with Sodium 4-(4-(2-hydroxynaphthalenylazo)phenylazo)benzenesulphonate(6406-56-0) by dermal application for 24 hours.
The above study was further supported by Sustainability Support Services (Europe) AB (study number: 18820, 2016-10-24) for the structurally similar read across substance Disodium 5-amino-4-hydroxy-3-(phenylazo) naphthalene-2, 7-disulphonate (CAS No. 3567-66-6).The acute dermal toxicity profile of Disodium 5-amino-4-hydroxy-3-(phenylazo) naphthalene-2, 7-disulphonate (3567-66-6) in Sprague Dawley rats. Water was used as vehicle.The test item was applied to shorn skin of 5 male and 5 female animals at 2000 mg/kg body weight. Administration of the test item at 2000 mg/kg did not result in any skin reaction at the site of application during the study period of 14 days. Administration of the test item did not result in any signs of toxicity and mortality during the study period of 14 days. Animals exhibited normal body weight gain through the study period of 14 days. Gross pathological examination did not reveal any abnormalities attributable to the treatment. Hence,the LD50 value was considered to be >2000 mg/kg bw,when male and female Sprague-Dawley rats were semiocclusively treated with Disodium 5-amino-4-hydroxy-3-(phenylazo) naphthalene-2, 7-disulphonate (3567-66-6)by dermal application following 14 days of observation period according to OECD Guideline 402 (Acute Dermal Toxicity).
Also these experimental results are further supported by Sustainability Support Services (Europe) AB (study number: 18818, 2016-10-24) for the structurally similar read across substance Tetra sodium 1-acetamido-2-hydroxy-3-(4-((4-sulphonatophenylazo)-7-sulphonato-1-naphthylazo))naphthalene-4,6-disulphonate (CAS No. 2519-30-4).The acute dermal toxicity profile of Tetra sodium 1-acetamido-2-hydroxy-3-(4-((4-sulpho natophenylazo)-7-sulphonato-1-naphthyl azo))naphthalene-4,6-disulphonate(CAS No. 2519-30-4) in Sprague Dawley rats.Distilled water was used as vehicle.The test item was applied to shorn skin of 5 male and 5 female animals at 2000 mg/kg body weight. Administration of the test item at 2000 mg/kg did not result in any skin reaction at the site of application during the study period of 14 days. Administration of the test item did not result in any signs of toxicity and mortality during the study period of 14 days. Animals exhibited normal body weight gain through the study period of 14 days.Gross pathological examination did not reveal any abnormalities attributable to the treatment.The LD50 value was considered to be >2000 mg/kg bw,when male and female Sprague Dawley rats were semiocclusively treated withTetra sodium 1-acetamido-2-hydroxy-3-(4-((4-sulphonatophenylazo)-7-sulphonato-1-naphthylazo))naphthalene-4,6-disulphonate (CAS No. 2519-30-4)by dermal application following 14 days of observation period according to OECD Guideline 402 (Acute Dermal Toxicity).
Thus, based on the above studies on Sodium 4-(4-(2-hydroxynaphthalenylazo)phenylazo)benzenesulphonate(6406-56-0) and it’s structurally similar read across substances, it can be concluded that LD50 value is greater than 2000 mg/kg bw. Thus, comparing this value with the criteria of CLP regulation, Sodium 4-(4-(2-hydroxynaphthalenylazo)phenylazo)benzenesulphonate(6406-56-0) cannot be classified for acute dermal toxicity.
Justification for classification or non-classification
Based on the above studies and prediction on Sodium 4-(4-(2-hydroxynaphthalenylazo)phenylazo)benzenesulphonate(6406-56-0) and it’s structurally similar read across substances, it can be concluded that LD50 value is greater than 2000 mg/kg bw. Thus, comparing this value with the criteria of CLP regulation, Sodium 4-(4-(2-hydroxynaphthalenylazo)phenylazo)benzenesulphonate(6406-56-0) cannot be classified for acute oral and dermal toxicity. For Acute inhalation toxicity wavier was added so, not possible to classify.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
